Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines. (2018)
Attributed to:
Epidemiological and statistical research on health problems of developing countries: MRC Tropical Epidemiology Group
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2018.02.062
PubMed Identifier: 29525283
Publication URI: http://europepmc.org/abstract/MED/29525283
Type: Journal Article/Review
Volume: 36
Parent Publication: Vaccine
Issue: 24
ISSN: 0264-410X